The Effect of Aerobic and Anaerobic Exercise on Oxidative Stress and Cellular Fitness in Healthy Trained Young Men
1 other identifier
interventional
20
1 country
1
Brief Summary
This study aims to analyze the effects of aerobic and anaerobic exercise on health at the molecular level. By examining these effects, the study seeks to provide the public with insights into which types of exercise offer the most significant health benefits. Participants will engage in aerobic and anaerobic exercises for one month, with 5 mL of venous blood collected by experienced phlebotomists both before and after the exercise period. While blood collection may cause mild discomfort and temporary bruising, these symptoms should subside within a few days. The collected blood will be processed to separate plasma and leukocytes for the assessment of oxidative damage, lipid profile and cellular fitness parameters. The oxidative damage markers to be measured include malondialdehyde (MDA) levels, H2O2, and antioxidants such as total antioxidant capacity, superoxide dismutase, and glutathione peroxidase. Cellular fitness will be evaluated by measuring mitochondrial biogenesis markers (succinate dehydrogenase and PGC-1A), ATP levels, and ATPase inhibitor levels. The benefits for the participants, they will receive include a laboratory assessment to evaluate cell damage, lipid profiles, and mitochondrial function. Additionally, the study results will help identify the most beneficial type of physical exercise for optimal health.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2024
CompletedFirst Submitted
Initial submission to the registry
August 27, 2024
CompletedFirst Posted
Study publicly available on registry
September 3, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2024
CompletedSeptember 3, 2024
August 1, 2024
4 months
August 27, 2024
August 30, 2024
Conditions
Outcome Measures
Primary Outcomes (5)
Concentration of Malondialdehyde (MDA)
MDA in nmoL/mL is measured using spectrophotometer from the subject's plasma
1 month
Concentration of Hydrogen Peroxide
Hydrogen peroxide in mmol/L is measured using spectrophotometer from the subject's plasma
1 month
Concentration of Superoxide dismutase (SOD)
SOD in U/mL is measured using spectrophotometer from the subject's plasma
1 month
Concentration of Total Antioxidant Capacity
Total Antioxidant Capacity in U/mL is measured using spectrophotometer from the subject's plasma
1 month
Concentration of Glutathione Peroxidase (GPx)
GPx in in U/mL is measured using spectrophotometer from the subject's plasma
1 month
Secondary Outcomes (4)
Concentration of Succinate Dehydrogenase (SDH)
1 month
Concentration of Peroxisome proliferator-activated receptor-gamma coactivator (PGC)-1alpha
1 month
Concentration of Adenosine triphosphate (ATP)
1 month
Concentration of ATPase inhibitor
1 month
Study Arms (2)
Pre aerobic exercise treatment
EXPERIMENTALSubject will do aerobic exercise 3 times a week for 1 month. The training program includes the following: Week 1 consists of interval running (2 sets of 10 repetitions of 400 meters each) with 3 minutes of rest between repetitions and 10 minutes of rest between sets. Week 2 transitions to continuous running for 15-20 minutes. Week 3 involves 30 minutes of cross-country running. In Week 4, the program returns to interval running as in Week 1.
Pre anaerobic exercise treatment
EXPERIMENTALSubject will do anerobic exercise 3 times a week for 1 month. The sprint training program includes the following: In Weeks 1 and 3, perform sprints of 20 m, 40 m, 60 m, and 80 m, with 2 sets of 5 repetitions each, allowing 5 minutes of rest between repetitions and 10 minutes of rest between sets. In Weeks 2 and 4, run 2 sets of 5 repetitions of 50 m sprints, with 5 minutes of rest between repetitions and 10 minutes between sets.
Interventions
Subjects will do aerobic and anaerobic exercise
Eligibility Criteria
You may qualify if:
- Male, aged 18-23.
- body weight of 56-70 kg and a height of 158-175 cm.
- Systolic blood pressure values below 130 mmHg, and diastolic blood pressure below 90 mmHg.
- maximum oxygen consumption (VO2max) is calculated to be greater than 40 mL/(kg-minute).
You may not qualify if:
- fever
- having chronic diseases (heart disease, lung disease)
- smoking
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Faculty of Medicine Universitas Indonesia
Jakarta Pusat, Jakarta Special Capital Region, 10430, Indonesia
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Novi Hardiany
Fakultas Kedokteran Universitas Indonesia
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Coordinator
Study Record Dates
First Submitted
August 27, 2024
First Posted
September 3, 2024
Study Start
June 1, 2024
Primary Completion
September 30, 2024
Study Completion
November 30, 2024
Last Updated
September 3, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share